SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of UnitedHealth Group Incorporated - UNH
Werte in diesem Artikel
NEW YORK, March 11, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of UnitedHealth Group Incorporated ("UnitedHealth" or the "Company") (NYSE: UNH). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980
The investigation concerns whether UnitedHealth and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
[Click here for information about joining the class action]
On February 27, 2024, The Wall Street Journal ("WSJ") reported that the U.S. Department of Justice ("DOJ") has launched an antitrust investigation into UnitedHealth. Specifically, the WSJ reported that DOJ investigators have been interviewing healthcare industry representatives in sectors where UnitedHealth competes to determine the possible impacts of acquisitions made through its health services arm, Optum.
On this news, UnitedHealth's stock price fell $27.04 per share, or 5.15%, over the following two trading sessions, to close at $498.28 per share on February 28, 2024.
Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered billions of dollars in damages awards on behalf of class members. See www.pomlaw.com.
Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
Danielle Peyton
Pomerantz LLP
dpeyton@pomlaw.com
646-581-9980 ext. 7980
View original content to download multimedia:https://www.prnewswire.com/news-releases/shareholder-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-unitedhealth-group-incorporated---unh-302085704.html
SOURCE Pomerantz LLP
Ausgewählte Hebelprodukte auf UnitedHealth
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf UnitedHealth
Der Hebel muss zwischen 2 und 20 liegen
Aktuelle UnitedHealth Aktie News
UnitedHealth Analysen
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für UnitedHealth nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen
| Datum | Rating | Analyst | |
|---|---|---|---|
| 14.04.22 | UnitedHealth Outperform | RBC Capital Markets | |
| 15.10.20 | UnitedHealth Outperform | Credit Suisse Group | |
| 14.10.20 | UnitedHealth Outperform | RBC Capital Markets | |
| 29.08.19 | UnitedHealth Outperform | Credit Suisse Group | |
| 17.07.18 | UnitedHealth buy | Goldman Sachs Group Inc. |
